NCT04792463 2026-03-09Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeOhio State UniversityRecruiting500 enrolled
NCT05075993 2025-12-26Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsM.D. Anderson Cancer CenterPhase 1 Active not recruiting352 enrolled
NCT03207347 2023-09-15A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)University of FloridaPhase 2 Completed37 enrolled 15 charts
NCT01773655 2020-07-01Clinical and Histopathologic Characteristics of BAP1 MutationsMemorial Sloan Kettering Cancer CenterCompleted196 enrolled
NCT00499733 2019-01-18Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase EARLY_PHASE1 Terminated19 enrolled